MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma

10.1158/1535-7163.MCT-15-0062

Saved in:
Bibliographic Details
Main Authors: Kong, Li Ren, Chua, Kian Ngiap, Sim, Wen Jing, Ng, Hsien Chun, Bi, Chonglei, Ho, Jingshan, Nga, Min En, Pang, Yin Huei, Ong, Weijie Richard, Soo, Ross Andrew, Huynh, The Hung, Chng, Wee Joo, Thiery, Jean-Paul, Goh, Boon Cher
Other Authors: BIOMED INST FOR GLOBAL HEALTH RES & TECH
Format: Article
Language:English
Published: American Association for Cancer Research Inc. 2020
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/175514
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English
id sg-nus-scholar.10635-175514
record_format dspace
spelling sg-nus-scholar.10635-1755142024-04-24T05:53:18Z MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma Kong, Li Ren Chua, Kian Ngiap Sim, Wen Jing Ng, Hsien Chun Bi, Chonglei Ho, Jingshan Nga, Min En Pang, Yin Huei Ong, Weijie Richard Soo, Ross Andrew Huynh, The Hung Chng, Wee Joo Thiery, Jean-Paul Goh, Boon Cher BIOMED INST FOR GLOBAL HEALTH RES & TECH CANCER SCIENCE INSTITUTE OF SINGAPORE BIOCHEMISTRY MEDICINE PATHOLOGY PHARMACOLOGY Science & Technology Life Sciences & Biomedicine Oncology PLATINUM-BASED CHEMOTHERAPY RANDOMIZED PHASE-III LUNG-CANCER MELANOMA-CELLS MUTATIONS KINASE GROWTH HEAD PROTEIN GENE 10.1158/1535-7163.MCT-15-0062 MOLECULAR CANCER THERAPEUTICS 14 7 1750-1760 United States 2020-09-10T01:57:50Z 2020-09-10T01:57:50Z 2015-07-01 2020-09-09T22:33:45Z Article Kong, Li Ren, Chua, Kian Ngiap, Sim, Wen Jing, Ng, Hsien Chun, Bi, Chonglei, Ho, Jingshan, Nga, Min En, Pang, Yin Huei, Ong, Weijie Richard, Soo, Ross Andrew, Huynh, The Hung, Chng, Wee Joo, Thiery, Jean-Paul, Goh, Boon Cher (2015-07-01). MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma. MOLECULAR CANCER THERAPEUTICS 14 (7) : 1750-1760. ScholarBank@NUS Repository. https://doi.org/10.1158/1535-7163.MCT-15-0062 15357163 15388514 https://scholarbank.nus.edu.sg/handle/10635/175514 en American Association for Cancer Research Inc. Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
language English
topic Science & Technology
Life Sciences & Biomedicine
Oncology
PLATINUM-BASED CHEMOTHERAPY
RANDOMIZED PHASE-III
LUNG-CANCER
MELANOMA-CELLS
MUTATIONS
KINASE
GROWTH
HEAD
PROTEIN
GENE
spellingShingle Science & Technology
Life Sciences & Biomedicine
Oncology
PLATINUM-BASED CHEMOTHERAPY
RANDOMIZED PHASE-III
LUNG-CANCER
MELANOMA-CELLS
MUTATIONS
KINASE
GROWTH
HEAD
PROTEIN
GENE
Kong, Li Ren
Chua, Kian Ngiap
Sim, Wen Jing
Ng, Hsien Chun
Bi, Chonglei
Ho, Jingshan
Nga, Min En
Pang, Yin Huei
Ong, Weijie Richard
Soo, Ross Andrew
Huynh, The Hung
Chng, Wee Joo
Thiery, Jean-Paul
Goh, Boon Cher
MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma
description 10.1158/1535-7163.MCT-15-0062
author2 BIOMED INST FOR GLOBAL HEALTH RES & TECH
author_facet BIOMED INST FOR GLOBAL HEALTH RES & TECH
Kong, Li Ren
Chua, Kian Ngiap
Sim, Wen Jing
Ng, Hsien Chun
Bi, Chonglei
Ho, Jingshan
Nga, Min En
Pang, Yin Huei
Ong, Weijie Richard
Soo, Ross Andrew
Huynh, The Hung
Chng, Wee Joo
Thiery, Jean-Paul
Goh, Boon Cher
format Article
author Kong, Li Ren
Chua, Kian Ngiap
Sim, Wen Jing
Ng, Hsien Chun
Bi, Chonglei
Ho, Jingshan
Nga, Min En
Pang, Yin Huei
Ong, Weijie Richard
Soo, Ross Andrew
Huynh, The Hung
Chng, Wee Joo
Thiery, Jean-Paul
Goh, Boon Cher
author_sort Kong, Li Ren
title MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma
title_short MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma
title_full MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma
title_fullStr MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma
title_full_unstemmed MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma
title_sort mek inhibition overcomes cisplatin resistance conferred by sos/mapk pathway activation in squamous cell carcinoma
publisher American Association for Cancer Research Inc.
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/175514
_version_ 1800914367471943680